Newly Discovered Molecular Marker Identifies Patients Most likely to Benefit form two Popular Cancer Drugs
Everyone's Blog Posts - Onco'Zine,
Results of a study by scientists at Johns Hopkins which was funded by the National Cancer Institute, identify a molecular…